Literature DB >> 15785176

Current status of mitral valve repair.

A Marc Gillinov1, Delos M Cosgrove.   

Abstract

Mitral valve repair is the procedure of choice to treat mitral valve dysfunction. Advantages of mitral valve repair over mitral valve replacement include improved long-term survival, better preservation of left ventricular function, and greater freedom from endocarditis, thromboembolism, and anticoagulant-related hemorrhage. The feasibility and durability of mitral valve repair depend upon the etiology of mitral valve dysfunction. In degenerative and ischemic mitral valve diseases, valve repair is possible in 90% of cases and freedom from reoperation is high. In contrast, rheumatic valves are less amenable to repair and durability is limited. Most isolated valve operations can be performed in a minimally invasive fashion using a partial upper sternotomy. In patients with atrial fibrillation and mitral valve disease, the Maze procedure or pulmonary vein isolation is performed, eliminating atrial fibrillation and the need for long-term anticoagulation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15785176     DOI: 10.1111/j.1541-9215.2003.02082.x

Source DB:  PubMed          Journal:  Am Heart Hosp J        ISSN: 1541-9215


  3 in total

Review 1.  Mitral valve surgery for mitral regurgitation caused by Libman-Sacks endocarditis: a report of four cases and a systematic review of the literature.

Authors:  Wobbe Bouma; Theo J Klinkenberg; Iwan C C van der Horst; Inez J Wijdh-den Hamer; Michiel E Erasmus; Marc Bijl; Albert J H Suurmeijer; Felix Zijlstra; Massimo A Mariani
Journal:  J Cardiothorac Surg       Date:  2010-03-23       Impact factor: 1.637

2.  An excellent result of surgical treatment in patients with severe pulmonary arterial hypertension following mitral valve disease.

Authors:  Xiaochun Song; Cui Zhang; Xin Chen; Yongming Chen; Qiankun Shi; Yongsheng Niu; Jilai Xiao; Xinwei Mu
Journal:  J Cardiothorac Surg       Date:  2015-05-13       Impact factor: 1.637

3.  Mitral valve restoration using the No-React(R) MitroFix™: a novel concept.

Authors:  Frank Oertel; Karl Golczyk; Sigrun Pantele; Vladimir Danov; Manuel Galiñanes; Michael Beyer
Journal:  J Cardiothorac Surg       Date:  2012-09-04       Impact factor: 1.637

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.